GLPG_OUT_1 [2025-04-14 11:14:20 -0400] 3702 Bytes | 955 tokens | Cum: 955 tkns (11.94% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Galapagos NV (GLPG) which is at 24.1600 up from 24.0100. So, I pulled together a bunch of data for you to look over real fast. It's still early, 11:14:19 AM on Mon Apr 14, 2025 -0400. So, what's the verdict? You're the expert!

--- COMPANY PROFILE ---
Company: Galapagos NV (GLPG)
IPO: 2015-05-14 (9 Years Ago)
Market Cap: $1,602,616,767
Shares Outstanding: 65,900,000
Exchange: XNAS
Description: Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Here’s the first list of news for Galapagos NV:

C1 - Apr-11-25 03:05PM - Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
C2 - Apr-01-25 11:50AM - Biotech stocks slide as Marks resignation seen being negative for sector
C3 - Mar-27-25 04:01PM - Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders' Meeting
C4 - Feb-24-25 04:01PM - Galapagos to Present at Upcoming Investor Conferences
C5 - Feb-17-25 04:01PM - Galapagos receives transparency notification and 13D filing from Tang Capital
C6 - Feb-12-25 04:01PM - Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
C7 - Jan-08-25 01:30AM - Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
C8 - Jan-07-25 04:01PM - Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**. I am **ScanScor**, a unified document retrieval and report parser.
Your role is to examine all available company data and draw sound conclusions.
The company under analysis is: Galapagos NV (GLPG).

2) To request information, refer to any listed documents using their reference codes.

3) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
At the end, you'll be prompted to return these data pairs:

1) BRIEF_SUMMARY[] -- Write a brief summary
2) MARKET_SCORE[] -- Assign a Market Score
3) PRICE_TARGET[] -- Set a price target
4) AI_RPT_HEADLINE[] -- Generate a headline for the article
5) SQUEEZE_POTENTIAL[] -- Potential for this stock to become an active short squeeze play
6) TAGS[] -- 1 to 4 words for SEO tags
7) STOCK_TYPE[] -- Describe the type of investor style suited to this stock
8) PRIMARY_CATALYST[] -- What you believe caused this stock to move today
9) SENTIMENT[] -- Mkt sentiment of the opportunity
10) IMPROVEMENT_SUGGESTION[] -- What can we do better
11) ETHICAL_RATING[] -- Rate alignment with long-term shareholder interests

Restrict the next response to just 3 tokes until it's time for the summary and data pairs at the end.
Request a document with its reference code(s), such as:
- `C1`, `C2`, `C3`, etc.
- To load more documents, reply with: `NEX`

News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.

GLPG_OUT_3 [2025-04-14 11:14:23 -0400] 492 Bytes | 157 tokens | Cum: 1114 tkns (13.93% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?**
Date: Apr-11-25 03:05PM
Source: (Insider Monkey)
URL: /news/22617/is-galapagos-glpg-the-top-healthcare-stock-to-buy-according-to-billionaire-david-einhorn

**No additional content available.**

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GLPG_OUT_5 [2025-04-14 11:14:23 -0400] 926 Bytes | 281 tokens | Cum: 1466 tkns (18.32% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-13T08:03:26Z - Norges Bank Acquires New Stake in Galapagos NV (NASDAQ:GLPG)...
A2 - 2025-04-11T19:05:02Z - Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?...
A3 - 2025-04-08T10:06:14Z - Galapagos NV (NASDAQ:GLPG) is Finepoint Capital LP's 10th Largest Position...
A4 - 2025-03-30T08:20:46Z - Galapagos NV (NASDAQ:GLPG) Given Consensus Recommendation of "Reduce" by Analysts...
A5 - 2025-03-27T20:27:45Z - Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders' Meeting...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

GLPG_OUT_7 [2025-04-14 11:14:27 -0400] 1098 Bytes | 327 tokens | Cum: 1795 tkns (22.44% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**Norges Bank Acquires New Stake in Galapagos NV (NASDAQ:GLPG)**Date: 2025-04-13Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/norges-bank-acquires-new-stake-in-galapagos-nv-nasdaqglpg-2025-04-11/Norges Bank purchased a new position in shares of Galapagos NV (NASDAQ:GLPG - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 120,000 shares of the biotechnology company's stock, valued at approximately $3,300,000. Norges Bank owned about 0.18% of Galapagos as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of GLPG. R Squared Ltd bought a new stake in shares of Galapagos in the 4th quarter valued at $26,000. GAMMA Investing LLC boosted its holdings in Galapagos by 77.4% during the 4th quar

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GLPG_OUT_9 [2025-04-14 11:14:28 -0400] 1144 Bytes | 384 tokens | Cum: 2266 tkns (28.32% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-01-08T19:07:38Z - Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
B2 - 2025-01-08T06:30:00Z - Galapagos wil aandeelhouderswaarde ontgrendelen met voornemen tot splitsing in twee beursgenoteerde entiteiten
B3 - 2025-01-08T06:30:00Z - Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
B4 - 2024-12-07T17:30:00Z - Galapagos kondigt bemoedigende nieuwe resultaten aan van de lopende fase 1/2-studie van de CD19 CAR T-celtherapie GLPG5101 bij patiënten met recidief/refractair non-Hodgkin lymfoom
B5 - 2024-12-07T17:30:00Z - Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
B6 - 2024-09-16T20:01:00Z - Galapagos ontvangt transparantieverklaring van EcoR1 Capital

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

GLPG_OUT_11 [2025-04-14 11:14:33 -0400] 777 Bytes | 207 tokens | Cum: 2475 tkns (30.94% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/25/01/42883679/galapagos-unveils-2025-split-to-accelerate-innovation-sharpen-strategic-focusGalapagos NV plans to split its operations into two entities - SpinCo and the core Galapagos company. SpinCo will focus on developing innovative medicines through strategic deals, while Galapagos will focus on its global cell therapy leadership in oncology. The restructuring will result in job cuts and reduced annual cash burn.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GLPG_OUT_13 [2025-04-14 11:14:34 -0400] 238 Bytes | 59 tokens | Cum: 2706 tkns (33.83% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

GLPG_OUT_15 [2025-04-14 11:14:40 -0400] 4749 Bytes | 1144 tokens | Cum: 3852 tkns (48.15% of 8k)
==========================================================================

This is our set of metrics for {co_name}.
Please analyze the numbers.

+---------------------+----------------------+-------------------------+-----------------------+
| Volume: 770,144 | Perf Month: -7.27% | Option/Short: Yes / Yes | Sales Y/Y TTM: - |
+---------------------+----------------------+-------------------------+-----------------------+
| Avg Volume: 270.71K | Perf Quarter: -0.50% | Short Float: 3.92% | ROE: - |
+---------------------+----------------------+-------------------------+-----------------------+
| Rel Volume: 10.66 | Index: - | Short Ratio: 6.91 | ROI: 2.63% |
+---------------------+----------------------+-------------------------+-----------------------+
| RSI (14): 42.92 | Market Cap: 1.59B | Short Interest: 1.87M | Sales Surprise: 8.11% |
+---------------------+----------------------+-------------------------+-----------------------+
| ATR (14): 0.78 | Shs Outstand: 65.90M | Beta: 0.04 | EPS Surprise: 152.69% |
+---------------------+----------------------+-------------------------+-----------------------+
| SMA20: -2.76% | Shs Float: 47.78M | Sales Q/Q: -38.32% | P/E: 20.07 |
+---------------------+----------------------+-------------------------+-----------------------+
| SMA50: -4.11% | Inst Own: 20.26% | Sales past 5Y: -15.00% | Earnings: Apr 23 AMC |
+---------------------+----------------------+-------------------------+-----------------------+
| SMA200: -9.54% | Insider Own: 27.50% | Employees: 704 | |
+---------------------+----------------------+-------------------------+-----------------------+
| Perf Week: 4.69% | Insider Trans: 0.00% | Debt/Eq: 0.00 | |
+---------------------+----------------------+-------------------------+-----------------------+

The next section covers any insider trading by {co_name} officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 24.16
Average Volume: 264889.48
30-Day High: 26.1
30-Day Low: 23.04
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Galapagos NV (GLPG).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Galapagos NV.

2) MARKET_SCORE[]
This conversation was initiated because GLPG is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for GLPG.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, GLPG could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect GLPG to increase 50% from its current price of $24.16, say: PRICE_TARGET[36.24]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Galapagos NV.

11) ETHICAL_RATING[]
Rate Galapagos NV’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

Return only: FIELD[value] for each of the above 11 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

GLPG_IN_17 [2025-04-14 11:14:40 -0400] 126 Bytes | 29 tokens | Cum: 4078 tkns (50.98% of 8k)
==========================================================================

====================================
[2025-04-14 11:14:40] # Analysis Completed
Elapsed Time: 21.40 seconds